NCPA - National Center for Policy Analysis

Daily Policy Digest

Health Issues

Louisiana Shows Coverage Does Not Equal Access

Louisiana has added 402,557 adults through Obamacare's Medicaid expansion as a result of Obamacare's expansion. However, only 62,742 received medical care as a result, writes NCPA Senior Fellow John R. Graham...

Medicare, Medicaid, Veterans Health At High Risk of Abuse in Government Report

The Government Accountability Office (GAO) has published its biennial update of federal programs "that it identifies as high risk due to their greater vulnerabilities to fraud, waste, abuse, and mismanagement..." Healthcare programs feature high on the list, writes NCPA Senior Fellow John R. Graham...

Health Spending and Prices to Rise Through 2025

Actuaries at the Centers for Medicare & Medicaid Services, a government agency, have just updated their estimate of future health spending. Spending on Medicare, Medicaid, and private insurance will increase faster than the recent past, making a mockery of Obamacare's claims, writes NCPA Senior Fellow John R. Graham...

American Patients Have Much, Much Better Access to Cancer Drugs Than Others Do

Of 45 anticancer drug indications approved in the United States between January 1, 2009, and December 31, 2013, 64 percent (29) were approved by the European Medicines Agency; 76 percent (34) were approved in Canada; and 71 percent (32) were approved in Australia between January 1, 2009, and June 30, 2014. The U.S. Medicare program covered all 45 drug indications; the United Kingdom covered 72 percent (21) of those approved in Europe -- only 47 percent (21) of the drug indications covered by Medicare. Canada and France covered 33 percent (15) and 42 percent (19) of the drug indications covered by Medicare, respectively, and Australia was the most restrictive country, covering only 31 percent (14), writes NCPA Senior Fellow John R. Graham...

It's Time to Rethink How We Manage, Pay for Care for The Sickest 10%

Americans are increasingly enrolling in health plans that reimburse none of their medical bills, but are costly nonetheless. Many day-to-day medical care costs are paid entirely out-of-pocket, writes NCPA Senior Fellow Devon Herrick...

Repealing Obamacare Is Good For California Jobs

Obamacare was a cash cow for providers, who now argue it was a program for jobs and economic growth. They now say that repealing Obamacare will kill California jobs. That grabs any politician's attention, but it is not true, writes NCPA Senior Fellow John R. Graham...

Celebrity Apprentice and Medical Innovation Have Something Important in Common

A new report should help President Trump find his way out of the confusion suggested by his very mixed signals on the role of medical innovation to American prosperity and patient. The same policies which protect his investment in reality TV ensure medical innovators can invest in research and development, writes NCPA Senior Fellow John R. Graham...

Who Is Responsible for Rising Drug Costs?

Americans’ prescription drug bills are rising. Most drugs are affordable, but prices for a few drugs exceed the average mortgage payment. They can be especially costly when there are only one, two or three patented drugs in a given therapeutic class. Drug makers are free to establish whatever price they believe the market will bear and, depending on the number of competitors, they could have significant pricing power.

Congressional Brief: 12 Fundamentals of Highly Effective Healthcare

Empowering Patients, Providers and the Private Sector by lowering costs, increasing quality and expanding access.

Health Construction Picked Up in December

Health facilities construction turned around in December, growing 0.6 percent versus a decline of 0.3 percent in starts for other construction. Health facilities construction accounted for almost 6 percent of non-residential construction starts. However, the growth was all in private health facilities.


« Newer « 4 5 6 7 8 9 10 11  Older »